|
|
Article: Leo Pharma A/S and Stiefel Laboratories Join Forces in Nordic Region to Market Stiefel's New Topical Anti-acne Rx Product.
- Article from:
- PR Newswire Europe
- Article date:
- January 12, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LONDON, January 12 /PRNewswire/ -- Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specialising in Dermatology, and LEO Pharma have joined forces in the Nordic region to market Stiefel's new topical anti-acne Rx product. This important new combination treatment is taking significant market share in countries where it is already launched (as DUAC(R) or CLINDOXYL(R) or INDOXYL(R)) in the US, Canada, the UK, Mexico, and it is expected that LEO will generate similar success in the Nordic region.
Charles W. Stiefel, President of Stiefel, says, "Part of our strategy is to build our business by partnering with other companies who ...